Castleview Partners’s Cohen & Steers CNS Stock Holding History

Castleview Partners’s Portfolio CNS Stock Details CNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,806	Closed	-$106	–	766
2021 Q4	$106	Buy	+9,806	New	+$908K	﹤0.01%	783

Other funds holding CNS

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Castleview Partners's CNS Position: Q1 2022 in Review

Castleview Partners sold out of Cohen & Steers (CNS) in Q1 2022, closing a stake of 9,806 shares — an estimated $106 sold.

Castleview Partners first reported a position in CNS in Q4 2021 and held it in 1 quarter. The position peaked at $106 in Q4 2021. 207 funds tracked by Wall St. Rank hold CNS as of Q1 2022.

Castleview Partners reported no remaining Cohen & Steers position as of Q1 2022 after selling out during the quarter.
Castleview Partners sold 9,806 Cohen & Steers shares in Q1 2022, an estimated $106.
Castleview Partners first reported a position in Cohen & Steers in Q4 2021 and held it in 1 quarter.
Castleview Partners's Cohen & Steers position peaked at $106 in Q4 2021.
207 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2022.

Based on Castleview Partners's 13F filing for Q1 2022, filed 16 May 2022.